Navigation Links
Medarex Announces July 10 Live Webcast of R&D Day Event
Date:7/7/2008

PRINCETON, N.J., July 7 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) invites investors, the media and the general public to listen to a live webcast of its 2008 R&D Day event. The webcast will begin on Thursday, July 10, 2008 at 8:00 a.m. Eastern Time and is expected to last approximately four hours. Members of Medarex's senior management will provide an overview of the company's strategy, progress and new information about advancements in the research and development pipeline and other ongoing programs.

Interested parties may access the live webcast through the Investor Relations section of the Medarex website at http://www.medarex.com. An archived edition of the event will be available for at least 14 days following the event.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 40 of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase 3 clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody product
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
2. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex Announces Election of Marc Rubin as New Board Member
7. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
8. Medarex Announces Completion of Sale of Shares in Genmab A/S
9. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
10. Medarex to Present at the Susquehanna Financial Group Healthcare Conference
11. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...to postmenopause , , MONTVALE, N.J., Dec. 2...nsity of vasomotor symptoms is a challenge for wom...he Journal of Family Practice have recently publi...ging the transition from perimenopause to postmeno... and Lee P. Shulman, MD, discuss the benefits of h...
(Date:12/2/2008)... -- eResearchTechnology, Inc.,(eRT), (Nasdaq: E...Clinical,technology, ePRO and other services to t...and related industries, announced today that Dr. M...hief Executive Officer, and Keith,Schneck, the Co...present at,the Piper Jaffray Health Care Conferen...
(Date:12/2/2008)...ted Cardiovascular Associates,(ACC), a 38-doctor ...tions in,Southern New Jersey, today announced tha...lth records and Sage Intergy practice management s...ich cares for more than 30,000 patients,annually,...ion to enhance care,delivery, clinical trial rese...
(Date:12/2/2008)...stCall/ -- Tianyin,Pharmaceutical, Co., Inc., (NY... modernized traditional Chinese medicine ("TCM") b...mentation of a new sales and marketing strategy to...s into three classes in order,to optimize their s...ategy has classified distributors into three class...
Breaking Biology Technology:eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 3Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 4Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 2Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 3
...is . - A Green Bay soil-technology company that us...products to market has won the 2006 Governor,s Sma...00 prize that comes with it. , , ENCAP, LLC , whi...nology products, was presented the award during th...ymposium presented by the Wisconsin Technology C...
...is. - CDW Corp. , the Illinois-based technology ...n Networks , is elevating a top salesman to handle...pany has put vice president of sales Steven Schuld...hnology solutions provider, into CDW. , ,CDW, head...ately-held Berbee on Oct. 11 for approximately $18...
...is. - Mirus Bio Corp. , a Madison-based biotechn... outside the U.S., that covers a method of treatin...ith an injection of genes. , ,The patent, titled "...method for delivering a wide range of therapeutic ... and compliments a patent already obtained in the ...
...is. -You,re in an elevator next to a venture capi...but doesn,t know the first thing about it yet. , ...That,s the premise of the Elevator Pitch Olympics,...osium . This year, a panel of eight investors dish...repreneurs who presented their businesses in front...
Other Biology Technology:Green Bay's ENCAP wins tech transfer award 2Mirus granted European patent for gene therapy 29 tips for making 90 seconds count in an investment pitch 2
(Date:12/1/2008)...vailable at the online site of the journal Biolog...orts for the first time that vitamin D induces imm...production of the antimicrobial protein cathelicid... trophoblast cells to the active form of vitamin D...reased antibacterial response in the trophoblast c...
(Date:12/1/2008)... The Missouri Botanical Garden Press (MBG Press) ...the species of vascular plants for the Southern Co.... Catlogo de las Plantas Vasculares del Cono Sur (... taxonomic checklist of the plants of Argentina, s...database is essentially a dictionary to the names ...
(Date:12/1/2008)..., R.I. [Brown University] Gray mold is a gardener...ific name Botrytis cinerea , is a scourge to more...s, including staples such as tomatoes, strawberrie...e, peas, peppers, and potatoes. Gray mold envelops...hat poisons the host plants, cells, eventually cau...
(Date:12/1/2008).... In the race for bioengineered crops, sequencing... multi-leg relay. Once the sequence is complete, t...ify genes, functions. A draft sequence of the soyb...me will be available soon. Taking the next step in...nary Plant Group researchers have demonstrated the...
Breaking Biology News(10 mins):Missouri Botanical Garden publishes first catalogue of plants of the Southern Cone 2Brown chemist finds gray mold's killer gene 2Tool helps identify gene function in soybeans 2Warburg Pincus Acquires 5 4 25 of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank 6535 1Warburg Pincus Acquires 5 4 25 of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank 6535 2Warburg Pincus Acquires 5 4 25 of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank 6535 3Nets Star Josh Boone Kicks Off Free Summer Meals Program 23965 1Warfarin Safer Than Heparin for Some Strokes 23963 1Warfarin Safer Than Heparin for Some Strokes 23963 2Closing coal burning power plant in China and improved cognitive development in children 23959 1Closing coal burning power plant in China and improved cognitive development in children 23959 2Closing coal burning power plant in China and improved cognitive development in children 23959 3
...ogists at the University at Buffalo have shown for...ing antifungal agent in saliva, kills the oral pat... most HIV-related oral infections. , Researchers ...at histatin binds to a specific membrane protein c...rough the cell membrane of the pathogenic fungus C...
...tients may one day benefit from treatment with mix...ed recently in the Proceedings of the National Aca...te scientists have demonstrated how the right comb...cell,s communication network, ultimately demobiliz...research led to the identification of a family of ...
...and Drug Administration (FDA) today announced a se...ing of the non-steroidal anti-inflammatory class o...n and non-prescription (over-the-counter (OTC)) no...ducts is available on the Internet at http://www.f...ay,s actions protect and advance the health of the...
... of a new technique to map connections among nerve...Center scientist dreaming of solving the mysteries... mouse brain stimulate others, researchers in Japa...on responsible for keeping animals awake receives ... sleep, as well as reinforcing, positive signals f...
Other Biology News:Discovery may lead to better Candidiasis drug 2Two are better than one 2FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 2Brain-mapping technique aids understanding of sleep, wakefulness 2Brain-mapping technique aids understanding of sleep, wakefulness 3
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C
TUP1 Market Segment: Molecular Biology
UbcH7 interacts with the HECT protein, E6-AP and the c-Cbl RING domain. Evidence suggests that this E2 is involved in both the degradation of non-""N-end rule"" protein substrates and of certain N-a
COMING SOON: Anti-Mouse C5a Receptor (CD88), Clone 10/92 Monoclonal Antibody
Biology Products: